| 专利名称 | CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated Disease | ||
| 申请号 | US16496821 | 申请日 | |
| 公开（公告）号 | US20200030286A1 | 公开（公告）日 | |
| 申请（专利权）人 | The General Hospital Corporation | 发明人 | Mark C Poznansky; Jeffrey Gelfand; Sara Pai |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
The present invention relates to methods and compositions for treating human papilloma virus (HPV)-associated diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for treating immune checkpoint blockade resistant diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for enhancing the immune response against an HPV-associated disease using an inhibitor of CXCL12 signaling. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
